Participants 389 437 5
patients with chronic idiopathic urticaria (CIU)
Participants 519 713 5
247 patients with CIU were randomised after a 1-week placebo run-in period to 10 mg daily mizolastine (n = 88), 10 mg daily loratadine (n = 79), or placebo (n = 80) for a 4-week treatment period
